Evidence map›Paper›PMID 30128021›Full record

ArticleOncology letters2018

Effect of As

Ke Ning, Wenlong Ning, Xiaoting Ning, Xueyan Wang, Fei Zhou

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. The Significance of Aldehyde Dehydrogenase 1 in Cancers.International journal of molecular sciences · 2024
    Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ke NingDepartment of Internal Neurology, Baotou Medical School, Inner Mongolia Medical University, Inner Mongolia 014000, P.R. China.
Wenlong NingDepartment of Emergency, The First Hospital of Qiqihar, Qiqihar, Heilongjiang 161005, P.R. China.
Xiaoting NingDepartment of ECG Room of Second Ward, The First Hospital of Qiqihar, Qiqihar, Heilongjiang 161005, P.R. China.
Xueyan WangDepartment of Public Health, The First Hospital of Qiqihar, Qiqihar, Heilongjiang 161005, P.R. China.
Fei ZhouSecond Department of Breast Surgery, The First Hospital of Qiqihar, Qiqihar, Heilongjiang 161005, P.R. China.
Qiqihar Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal carcinoma (CRC) is one of the most common types of malignant tumor in humans, and its morbidity is on the increase in economically transitioning countries. Due to its high toxicity, the use of the Chinese Traditional Medicine arsenic (As

Indexed as

aldehyde dehydrogenase 1As2O3cancer stem cellscolorectal carcinomaprimary cell culture

Identifiers

PMID30128021
PMCPMC6096221
OpenAlexW2865135525

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.